...
首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Retrograde transport of γ‐secretase from endosomes to the trans‐Golgi network regulates Aβ42 production
【24h】

Retrograde transport of γ‐secretase from endosomes to the trans‐Golgi network regulates Aβ42 production

机译:将γ-分泌酶的逆行传输从内体到Trans-Golgi网络调节Aβ42生产

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract The aberrant metabolism of amyloid‐β protein (Aβ) in the human brain has been implicated in the etiology of Alzheimer disease ( AD ). γ‐Secretase is the enzyme that generates various forms of Aβ, such as Aβ40 and Aβ42, the latter being an aggregation‐prone toxic peptide that is involved in the pathogenesis of AD . Recently, we found that clathrin‐mediated endocytosis of γ‐secretase affects the production and deposition of Aβ42 in?vivo , suggesting that the membrane trafficking of γ‐secretase affects its enzymatic activity. However, the detailed intracellular trafficking pathway of γ‐secretase and its contribution to Aβ42 generation remain unclear. Here, we show that Retro‐2, which inhibits the retrograde transport, elevated the Aβ42‐generating activity both in cultured cells and mice brain. However, the result of in?vitro γ‐secretase assay using a recombinant substrate suggested that Retro‐2 did not elevate the intrinsic Aβ42‐production activity of γ‐secretase. Immunocytochemistry and cell‐surface biotinylation experiments revealed that γ‐secretase is recycled via the endosome‐to‐ trans ‐Golgi network transport. In addition, γ‐secretase is retrogradely transported by syntaxin 5/6, known as targets of Retro‐2, independent pathway. Conversely, TPT ‐260, which enhances the trafficking function of retromers, lowered Aβ42 levels and the Aβ42/(Aβ40?+?Aβ42) ratio in secreted Aβ from cultured cells. Our results strongly suggest that the endosome‐to‐ trans ‐Golgi network trafficking of γ‐secretase regulates its Aβ42 production activity. Modulation of this trafficking pathway might be a potential target for the development of Aβ42‐lowering AD therapeutics. Open Practices Open Science: This manuscript was awarded with the Open Materials Badge. For more information see: https://cos.io/our-services/open-science-badges/
机译:摘要人脑中淀粉样蛋白-β蛋白(Aβ)的异常代谢涉及阿尔茨海默病的病因(AD)。 γ-分泌酶是产生各种形式的Aβ的酶,例如Aβ40和Aβ42,后者是参与AD的发病机制的聚集易受毒性肽。最近,我们发现Clathrin介导的γ-分泌酶的内吞作用影响Aβ42在β42中的产生和沉积,表明γ-分泌酶的膜流量影响其酶活性。然而,γ-分泌酶的详细细胞内贩运途径及其对Aβ42代的贡献仍然不清楚。在这里,我们表明Retro-2抑制逆行传输,升高了培养细胞和小鼠脑中的Aβ42产生活性。然而,使用重组底物的体外γ-分泌酶测定的结果表明Recro-2没有提高γ-分泌酶的内在Aβ42-生产活性。免疫细胞化学和细胞表面生物素化实验表明,γ-分泌酶通过内体 - 反式 - 原醇网络传输再循环。此外,γ-分泌酶通过棘突5/6逆行,称为Retro-2,独立途径的靶标。相反,TPT -260增强了来自培养细胞的分泌的Aβ的贩运函数,降低了Aβ42水平和Aβ42/(Aβ40?+αaβ42)的比例。我们的结果强烈表明,内体 - 转基因的网络贩运γ-分泌酶调节其Aβ42的生产活动。这种贩运途径的调制可能是开发Aβ42降低疗法的潜在目标。开放实践公开科学:此手稿是授予开放材料徽章的奖励。有关更多信息,请参阅:https://cos.io/our-services/open-science-badges/

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号